Skip to main content
. 2021 Nov;16(11):1755–1765. doi: 10.2215/CJN.04560421

Figure 2.

Figure 2.

Summary of data against and in favor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in kidneys from patients with coronavirus disease 2019 (COVID-19). Number and percentage of patients in whom SARS-CoV-2 spike or nucleocapsid protein or RNA was detected (red) or not (blue). Each circle depicts immunohistochemistry, immunofluorescence, RT-PCR, or in situ hybridization. Data extracted from Tables 2 and 3.